Data

Growth Strategy Analysis examines organic and inorganic growth drivers, pipeline trends, and strategic initiatives from filings and earnings materials. Use it to assess growth trajectory, M&A strategy, and expansion plans for an investment decision.

Operational KPI analyzes structured financial data for operating trends like headcount, utilization, backlog, book-to-bill, and efficiency. Use it when you need quarter-over-quarter operational metrics from ticker-based filings and XBRL facts.

Peer Bench selects biotech and pharma peers by drug or indication overlap and compares pipeline depth, catalyst density, cash runway, margins, and valuation. Use it for med peer sets, comp tables, and relative valuation checks.

Pipeline Analysis maps a biotech or pharma company’s disclosed assets by phase, indication, and next catalyst, then frames risk-adjusted value and cash runway. Use it for clinical-stage companies, devices, and peer pipeline comparisons.

Recent Quarter Performance analyzes the most recent fiscal quarter for a ticker using XBRL facts, earnings calendar data, and transcript references. Use it to review revenue, EPS, margins, and sequential growth versus consensus and prior periods.

Recent Quarter Review summarizes a biotech company’s latest quarter with financial results, pipeline milestones, and FDA/regulatory events. Use it when you need a quarter readout that includes runway and clinical progress, not just standard earnings metrics.

Revenue Decomposition analyzes structured financial data to break revenue into segments, geographies, products, and channels. Use it to assess revenue mix, concentration, and business unit performance from reported company facts.

Risk Analysis assesses regulatory, competitive, macro, litigation, financial, operational, and geopolitical risks for an investment decision. Use it when you need a structured review of downside exposure from SEC filings and related disclosures.

Sector Overview frames the med sector by taxonomy, catalysts, and recent trends before a deeper company analysis. Use it to map biotech, pharma, devices, and related FDA-driven context.

Secular Trends analyzes long-term technology adoption cycles, disruption risk, AI impact, and competitive positioning for companies or industries. Use it for investment research on moats, innovation trajectory, and R&D effectiveness.

Skywork Excel creates spreadsheets, charts, and analysis reports from user prompts and data files. It can also pull live web data, convert formats, and generate financial models or dashboards.

Turnaround Analysis reviews SEC filings and earnings transcripts to detect stagnation, recovery, and operational inflection points. Use it for business transformation, restructuring, cost cutting, and management change impact analysis.